Abstract

Summary

Chronotherapy leverages circadian rhythms to optimize the timing of cancer treatments—including chemotherapy, radiotherapy, and immunotherapy—maximizing efficacy while minimizing toxicity. Despite over 50 years of evidence showing benefits across diverse solid tumor types, clinical implementation remains limited, suggesting that lighting environments in oncology settings that support robust circadian entrainment could enhance treatment outcomes.
Abstract

Key Findings

  • Chronotherapy for cancer treatment has demonstrated benefits across diverse solid tumor types over more than five decades of research.
  • Chrono-chemotherapy, chrono-radiotherapy, hormone therapy, TKIs, antiangiogenic therapy, and immunotherapy all show evidence of circadian-time-dependent efficacy differences.
  • Despite favorable evidence, clinical implementation of cancer chronotherapy remains limited, with ongoing research challenges in standardizing timing protocols.
  • Circadian disruption (e.g., from poor light-dark cycles) may undermine the synchronization of physiological processes that chronotherapy depends upon.
Categories

Categories

Patient Recovery: Reviews chronotherapy for solid tumor treatment, showing how circadian-timed drug and radiation delivery improves therapeutic efficacy and reduces side effects in cancer patients.
Sleep & Circadian Health: Examines how circadian rhythm synchronization underlies the biological rationale for timed cancer treatments, with implications for light-dark cycle management in oncology care.
Authors

Author(s)

CO Kisamore, BD Elliott, AC DeVries, RJ Nelson
Publication Date

Publication Year

2023
Citations

Number of Citations

1
View more publications